Darmstadt, November 25, 2022 – The flu season has begun and different virus variants are also circulating in Germany. With the flu tests from biotechnology company R-Biopharm, patients quickly have certainty: Its RIDA®GENE Flu assays also reliably detect the two novel variants. The company made the announcement with regard to influenza A H1N1pdm09, which is… Read More »
BARCELONA, Spain — Julio Miranda had never felt the threat of the coronavirus too close. With an appointment for his first COVID-19 jab scheduled for mid-July, the 48-year-old house painter was, like many in the vaccine-abundant developed world, eagerly awaiting the end of his personal pandemic worries. Then a colleague fell ill last month, followed… Read More »
Loading the player… South African President Cyril Ramaphosa announced Sunday that his country will return to stricter lockdown measures in the face of a sharp rise in COVID-19 cases that indicate the virus is “surging again” in Africa’s worst-affected nation. Positive cases in South Africa in the past seven days were 31% higher than the… Read More »
BREAKDOWN OF MELBOURNE’S 15-CASE WHITTLESEA OUTBREAK * Case one – male in his 30s, tested Sunday, positive on Monday. * Case two – male in his 70s, went with case one to be tested. Also tested positive. Same family but different household. * Cases three and four – a woman in her 70s and a… Read More »
Researchers at the University of Zurich have developed a virus-based therapy that causes a tumor to destroy itself. They modified an adenovirus, which is a common virus that typically infects the respiratory tract and which is already widely used in medicine, to deliver genetic material that codes for an anti-cancer protein. In a sneaky move,… Read More »